Intech Investment Management LLC boosted its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 65.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,450 shares of the medical research company’s stock after acquiring an additional 6,526 shares during the quarter. Intech […]
Edwards Lifesciences Co. (NYSE:EW – Get Free Report) shares were up 0.2% during trading on Wednesday . The stock traded as high as $87.33 and last traded at $87.20. Approximately 301,329 shares were traded during trading, a decline of 91% from the average daily volume of 3,509,492 shares. The stock had previously closed at $87.04. […]
Edwards Lifesciences Co. (NYSE:EW – Get Free Report) fell 1.4% during mid-day trading on Tuesday . The company traded as low as $86.75 and last traded at $86.76. 316,813 shares changed hands during trading, a decline of 91% from the average session volume of 3,518,682 shares. The stock had previously closed at $87.98. Analyst Ratings […]
Edwards Lifesciences has petitioned the full Federal Circuit to narrow its interpretation of a U.S. Food and Drug Administration safe harbor that essentially allows patent infringement during drug development, arguing that if Congress wanted the statute to be interpreted broadly, "it would have said exactly that."
DSM Capital Partners LLC bought a new stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 371 shares of the medical research company’s stock, valued at approximately $28,000. Other institutional investors and hedge […]